Latest news
25 items- SECSEC Form 15-12G filed by PLx Pharma Inc.15-12G - PLx Pharma Winddown Corp. (0001497504) (Filer)
- SECPLx Pharma Inc. filed SEC Form 8-K: Bankruptcy or Receivership, Other Events, Financial Statements and Exhibits8-K - PLx Pharma Winddown Corp. (0001497504) (Filer)
- SECPLx Pharma Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits8-K - PLx Pharma Winddown Corp. (0001497504) (Filer)
- SECPLx Pharma Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits8-K - PLx Pharma Winddown Corp. (0001497504) (Filer)
- SECPLx Pharma Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits8-K - PLx Pharma Winddown Corp. (0001497504) (Filer)
- SECPLx Pharma Inc. filed SEC Form 8-K: Leadership Update, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits8-K - PLx Pharma Winddown Corp. (0001497504) (Filer)
- SECPLx Pharma Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits8-K - PLx Pharma Winddown Corp. (0001497504) (Filer)
- SECPLx Pharma Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Bankruptcy or Receivership, Completion of Acquisition or Disposition of Assets, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Other Events, Financial Statements and Exhibits8-K - PLx Pharma Winddown Corp. (0001497504) (Filer)
- SECSEC Form 25-NSE filed by PLx Pharma Inc.25-NSE - PLx Pharma Inc. (0001497504) (Subject)
- NEWSPLx Pharma Says Each Of Debtors Continue To Operate Business As 'Debtor-In-Possession' Under Jurisdiction of Bankruptcy Court-SEC Filing
- NEWSPLx Pharma Says Co. And Its Unit, PLx Opco Filed Voluntary Petitions For Relief Under Chapter 11 Of Title 11 Of United States Bankruptcy Code-SEC Filing
- SECPLx Pharma Inc. filed SEC Form 8-K: Bankruptcy or Receivership, Financial Statements and Exhibits8-K - PLx Pharma Inc. (0001497504) (Filer)
- SECPLx Pharma Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits8-K - PLx Pharma Inc. (0001497504) (Filer)
- NEWSPLx Pharma Enters Into Stalking Horse Asset Purchase Agreement To Sell VAZALORE For $100K In Cash, Plus Credit Bid Of $3M
- PRPLx Pharma Inc. Enters into a Stalking Horse Asset Purchase Agreement to Sell VAZALORE® and Substantially All of its AssetsSPARTA, N.J., April 12, 2023 (GLOBE NEWSWIRE) -- PLx Pharma Inc. (NASDAQ:PLXP) ("PLx" or the "Company"), is a commercial-stage drug delivery platform technology company focused on its clinically-validated and patent-protected PLxGuard™ and VAZALORE®, an FDA-approved liquid-filled aspirin capsule, available in 81 mg and 325 mg doses. The Company today announced that it entered into a stalking horse asset purchase agreement (the "APA") with PLx Acquisition Company, LLC, a wholly-owned subsidiary of Greenwood Brands, LLC ("Buyer"), to acquire substantially all of the Company's assets (the "Sale"). The Company intends to file voluntary petitions for relief under Chapter 11 of Title 11 of the
- NEWSTop Reddit Short Squeeze Mentions For Wednesday April 12, 2023: AMC, BBBY, TRKA, GME, CLNN, NVOS, NCMI, NEGG, PLXP, SPCE
- NEWS12 Health Care Stocks Moving In Wednesday's Intraday SessionGainers Creative Medical Tech (NASDAQ:CELZ) stock moved upwards by 105.5% to $0.99 during Wednesday's regular session. As of 13:30 EST, this security is trading at a volume of 75.9 million shares, making up 2955.5% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $13.9 million. Bullfrog AI Hldgs (NASDAQ:BFRG) shares rose 31.32% to $5.66. The current volume of 5.0 million shares is 288.0% of Bullfrog AI Hldgs's average full-day volume over the last 100 days (last updated at 13:30 EST). The company's market cap stands at $31.9 million. X4 Pharmaceuticals (NASDAQ:XFOR) stock rose 28.77% to $1.22. The current volume of 9.1 million share
- NEWSWhy PLx Pharma Shares Are Nosediving TodayPLx Pharma (NASDAQ:PLXP) shares are trading lower after the company announced it received a NASDAQ delisting notice. What Happened: On Tuesday, PLx Pharma released an announcement that the Nasdaq is not giving the company another 180-day period to comply with its listing rules. Shares of PLXP stock will be delisted on Thursday. The Details: On Oct. 3, 2022, the company announced that it was notified by the listing qualifications department, determining it was intending to delist the company. The department cited a period of 30 consecutive days where PLx closing below $1.00 per share. Additionally, the company failed to file its form 10k for the period ending Dec 31, 2022. The company anno
- NEWS12 Health Care Stocks Moving In Wednesday's Pre-Market SessionGainers Creative Medical Tech (NASDAQ:CELZ) shares increased by 154.1% to $1.23 during Wednesday's pre-market session. The market value of their outstanding shares is at $17.3 million. Cyclo Therapeutics (NASDAQ:CYTH) stock rose 22.47% to $0.85. The company's market cap stands at $8.9 million. NeuroOne Medical Tech (NASDAQ:NMTC) shares increased by 11.48% to $1.99. The company's market cap stands at $32.5 million. Exscientia (NASDAQ:EXAI) stock increased by 9.66% to $5.98. The market value of their outstanding shares is at $737.1 million. Akari Therapeutics (NASDAQ:AKTX) stock rose 9.58% to $0.2. The market value of their outstanding shares is at $14.8 million. GT Biopharma (NASDAQ:GTB
- NEWSWhy iMedia Brands Shares Are Trading Higher By Over 13%; Here Are 20 Stocks Moving PremarketGainers HeartCore Enterprises, Inc. (NASDAQ:HTCR) jumped 119.6% to $1.96 in pre-market trading. HeartCore forged an agreement with rYojbaba Inc for its tenth Go IPO consulting service win. Altamira Therapeutics Ltd. (NASDAQ:CYTO) gained 81.8% to $2.40 in pre-market trading after dropping 36% on Tuesday. Liquid Media Group Ltd. (NASDAQ:YVR) climbed 54.4% to $0.23 in pre-market trading after dropping 17% on Tuesday. Liquid Media Group recently announced it received an additional deficiency notice from Nasdaq. Panbela Therapeutics, Inc. (NASDAQ:PBLA) gained 48.8% to $0.6444 in pre-market trading after gaining 5% on Tuesday. Panbela regained worldwide rights to develop and commercialize
- NEWSPLx Pharma shares are trading lower after the company announced it received a Nasdaq delisting notice.
- NEWSPLx Pharma Receives Nasdaq Delisting Notice
- PRPLx Pharma Inc. Receives Nasdaq Delisting NoticeSPARTA, N.J., April 11, 2023 (GLOBE NEWSWIRE) -- PLx Pharma Inc. (NASDAQ:PLXP) ("PLx" or the "Company"), is a commercial-stage drug delivery platform technology company focused on its clinically-validated and patent-protected PLxGuard™ that has the potential to improve the absorption of many drugs currently on the market and to reduce the risk of stomach injury associated with certain drugs. The Company had previously announced that on October 3, 2022, it was notified by the Listing Qualifications Department (the "Listing Qualifications Department") of the Nasdaq Stock Market LLC ("Nasdaq") that the Listing Qualifications Department has determined to delist the Company's securities from Na
- NEWSDow Surges Over 150 Points; Innovative Eyewear Shares Spike HigherU.S. stocks traded mostly higher toward the end of trading, with the Dow Jones gaining over 150 points on Tuesday. The Dow traded up 0.49% to 33,751.82 while the NASDAQ fell 0.05% to 12,077.79. The S&P 500, also rose, gaining, 0.31% to 4,121.98. Check This Out: FedEx, Ross Stores And 2 Other Stocks Insiders Are Selling Leading and Lagging Sectors Energy shares rose by 1.2% on Tuesday. Meanwhile, top gainers in the sector included BP Prudhoe Bay Royalty Trust. (NYSE:BPT), up 13%, and Tellurian Inc. (NASDAQ:TELL), up 10%. In trading on Tuesday, information technology fell by 0.7%. Top Headline Albertsons Companies Inc (NYSE:ACI) reported better-than-expected fourth-quarter results
- NEWS12 Health Care Stocks Moving In Tuesday's Intraday SessionGainers Innovative Eyewear (NASDAQ:LUCY) shares moved upwards by 146.6% to $3.6 during Tuesday's regular session. Innovative Eyewear's stock is trading at a volume of 58.1 million shares as of 13:30 EST. This is 3600.4% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $27.7 million. IMAC Hldgs (NASDAQ:BACK) stock increased by 59.61% to $0.2. Trading volume for IMAC Hldgs's stock is 79.6 million as of 13:30 EST. This is 42668.6% of its average full-day volume over the last 100 days. The company's market cap stands at $6.6 million. Reshape Lifesciences (NASDAQ:RSLS) shares moved upwards by 37.73% to $3.65. Trading volume for Reshape L
PLXP FAQ
7 questionsWhat does PLx Pharma Inc. do?
PLx Pharma Inc., a specialty pharmaceutical company, focuses on developing the PLxGuard drug delivery system to provide various products in the United States. The company's lead product candidates are Vazalore 325 mg and Vazalore 81 mg, which are formulations of aspirin that use the PLxGuard delivery system, which provides patients with vascular disease and diabetic patients who are candidates for aspirin therapy based on physician recommendation, with fast, reliable, and predictable platelet inhibition as compared to enteric-coated aspirin, as well as reduces the risk of stomach erosions and...Where does PLXP stock trade?
PLx Pharma Inc. (PLXP) is listed on NASDAQ.What sector and industry is PLXP in?
PLx Pharma Inc. operates in the Health Care sector, Biotechnology: Pharmaceutical Preparations industry.When did PLx Pharma Inc. go public?
PLx Pharma Inc. (PLXP) completed its IPO in 2014.What are analysts saying about PLXP?
PLx Pharma Inc. has had 2 recent analyst actions on file. The most recent action was from Raymond James: Outperform with a $1400.00 price target on 2021-12-07. Recent price targets range from $1400.00 to $2900.00.What companies are similar to PLXP?
Notable peers in the same industry include LLY (Eli Lilly and Company), JNJ (Johnson & Johnson), AZN (AstraZeneca PLC), ABBV (AbbVie Inc.), MRK (Merck & Company Inc.). Compare PLXP side-by-side with any of them on Quantisnow.How can I track PLXP on Quantisnow?
Quantisnow aggregates PLx Pharma Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow PLXP to receive live email and push alerts on every new disclosure.